Why Indian Drug Makers Challenge Global Patents
Explore the high-stakes legal battles between Indian generic manufacturers and global pharma giants. Understand the impact on drug prices, accessibility, and the evolving IP landscape in India.
Category : Search result: Novo Nordisk India
Natco Files to Revoke Novo Nordisk's Wegovy Patent in India
Hyderabad's Natco Pharma petitions Delhi High Court to revoke Novo Nordisk's semaglutide patent. The legal battle shapes India's future weight-loss drug market as 2026 patent expiry nears. Read more.
Japanese firms expand India tech centres to tap talent
Japanese giants like MUFG, Nidec, and Polyplastics are setting up tech centres in India. Driven by an ageing population and China risk, they aim to tap India's deep talent pool for AI, cybersecurity, and engineering. Read more.
NZ PM Calls India FTA a Landmark Deal for Jobs & Growth
New Zealand PM Christopher Luxon hails the historic Free Trade Agreement with India as a major boost for jobs, exports, and economic growth. Key details inside.
Novo Nordisk launches Wegovy weight-loss pill in US
Novo Nordisk launches oral Wegovy weight-loss drug in the US, priced at $299. The pill, approved in Dec 2025, aims to regain market share from rival Eli Lilly. UK approval expected end-2026.
Atul Vivek Named CEO of Nxtcell India, Alcatel Brand
Nxtcell India appoints Atul Vivek as CEO effective Jan 1, 2026. With 20 years of leadership experience from Realme, Samsung, and others, he will drive Alcatel's smartphone and AIoT expansion. Read more.
Shark Tank India Season 5: New Sharks, Release Time
Shark Tank India Season 5 premieres Jan 5, 2026, with new sharks joining the panel. Get all details on judges, timing, and where to watch the business reality show.
Novo Nordisk: Wegovy Price Cut to Boost India Obesity Therapy 5-7x
Novo Nordisk expects India's obesity drug market to grow rapidly after a 37% Wegovy price cut, mirroring insulin uptake. Generic competition looms with a Rs 5000-crore opportunity.
India's 2026 Hiring Boom: 12 Million Jobs Expected
Indian companies plan a major hiring surge in 2026, creating 10-12 million jobs. Driven by tech and diversity goals, firms like EY, Tata Motors, and Diageo are expanding teams. Read the full outlook.
India's 2025 Auto Boom: JSW MG, M&M, Kia, Skoda Lead Growth
India's auto sector ended 2025 with robust growth. JSW MG, Mahindra, Kia & Skoda reported record sales, driven by EVs and strong demand. Get all the key figures and insights here.
Weight-Loss Pill Race in 2026: Lilly Leads Novo Nordisk
Novo Nordisk and Eli Lilly to launch oral GLP-1 drugs in 2026. Despite Novo's head start, analysts predict Lilly's market leadership in obesity and diabetes treatments will persist for years. Explore the details.
US Vlogger's Emotional Farewell to India Goes Viral
A US-based vlogger's heartfelt goodbye video from India, filmed on a two-wheeler, goes viral. He shares how the country's warmth and daily life changed his perspective. Read his emotional journey.
India's 2026 Foreign Policy: Key Challenges & Opportunities
As India enters 2026, it faces critical tests in trade talks with the US, volatile neighbours, and balancing great-power ties. This analysis explores Delhi's strategic choices in a fractured world.
India's 2026 Diplomacy: Balancing Autonomy & Ambition
After a turbulent 2025 marked by conflict and trade wars, India enters 2026 with crucial choices on Pakistan, US ties under Trump, and key summits. Explore the high-stakes diplomatic roadmap ahead.
2025's Top Smartphone Launches in India: Full List
A comprehensive look at the biggest smartphone launches in India for 2025, featuring Samsung, Apple, Google, OnePlus, Xiaomi, and more. Discover the flagships and budget kings that defined the year.
India's 2025: Trade Deals, West Asia Outreach & Neighbourhood Strains
A look back at India's 2025: navigating US tariffs, sealing key trade pacts, expanding in West Asia, and facing military confrontation with Pakistan. Explore the year's diplomatic highs and lows.
FDA Approves Daily Wegovy Pill for Weight Loss
US FDA approves Novo Nordisk's daily Wegovy pill, an oral alternative to injections. Priced from $149, it offers 14% average weight loss. Details on cost, side effects, and how it compares to rivals.
Novo Nordisk stock jumps 7% on FDA approval for Wegovy pill
Shares of Novo Nordisk surged over 7% after its weight loss drug Wegovy pill received US FDA approval on December 22, 2025. Read the full market impact analysis.
First Weight-Loss Pill Approved in US, Priced $149/Month
US FDA approves Novo Nordisk's Wegovy Pill, first oral GLP-1 drug for weight loss. Priced at $149/month, it promises wider access and challenges injectable dominance. Read more.
Emcure Enters Obesity Market with Novo Nordisk's Semaglutide
Emcure Pharmaceuticals launches Poviztra, a weekly semaglutide injection for weight loss, in partnership with Novo Nordisk. Priced from ₹2,200 per week, it targets India's massive obesity market.
Explained: India's Free Trade Agreements and Key Partners
India is actively reshaping its trade policy with new FTAs. Explore the signed deals, ongoing talks, and the strategic impact on exports and the economy. Read more.
India-Oman Joint Statement Outlines Roadmap for Deeper Cooperation
India and Oman have unveiled a comprehensive joint vision document to enhance cooperation in trade, energy, maritime security, and people-to-people ties. Explore the key agreements shaping this strategic partnership.
US Embassy Shares JD Vance's Message on Strong India Ties
The US Embassy in India highlights VP nominee JD Vance's praise for bilateral ties, calling India a friend. Explore the strategic importance and future of India-US relations.
Court Rejects Ozempic Patent Extension, Boosts Generic Drug Access
Delhi High Court rejects Novo Nordisk's patent plea on semaglutide (Ozempic/Wegovy), preventing 'evergreening'. A win for affordable generics in India, but raises concerns over non-clinical misuse of weight-loss drugs. Read more.
US Officials Visit India for Trade Talks, AI & Space Collaboration
Senior US State Department official Allison Hooker and trade negotiators arrive in India to strengthen economic ties, discuss tariffs, and foster AI and space collaboration. Key meetings scheduled in New Delhi and Bengaluru.
India-Russia Summit: Trade to Hit $100B, New Deals Signed
India and Russia deepen strategic ties, signing agreements in trade, energy, and tech, aiming for $100 billion trade by 2030. Can this offset US tariff pressures?
Delhi HC sides with Dr Reddy's in semaglutide patent case
Delhi High Court rejects Novo Nordisk's plea for interim injunction against Dr Reddy's Labs over semaglutide. Court cites 'evergreening', allows DRL to export. Key ruling for diabetes drug market.
India's Drug Patent Wars: Need for Special Courts?
A recent Delhi High Court order in the Novo Nordisk vs Dr Reddy's case highlights the complexities of Indian patent litigation. We examine the system's challenges and the push for specialized IP courts.
American Mom's Viral Post on India vs US Culture
Anna Haakenson's viral Instagram post details 9 cultural contrasts between India and the US after a 2.5-month family trip. Discover the insights sparking global discussion.
Putin's India Visit: Oil, Defence & US Pressure
As Putin visits India, the world watches how New Delhi will balance discounted Russian oil, defence needs, and US pressure. Will India secure its autonomy or face new sanctions?
Page 1 of 4